Disease or Syndrome – Page 70

MAHA Commission, Robert F. Kennedy Jr., childhood chronic diseases, HHS Secretary, Executive Order, public health, chronic illness, disease prevention

Bambusa Therapeutics Secures $90M Series A Funding to Advance Bispecific Antibodies for I&I Disorders

9 months ago talkbio0Tagged Antibodies, Bispecific, Bambusa Therapeutics, Capital Management, Funding, Immunology, Inflammation, Rheumatoid Arthritis, Series

Bambusa Therapeutics, bispecific antibodies, immunology, inflammation, Series A funding, RA Capital Management, I&I disorders

Galderma’s Nemluvio Secures Dual EU Approvals for Atopic Dermatitis and Prurigo Nodularis

9 months ago talkbio0Tagged Commission approval, Dermatitis, Atopic, European (ethnic group), Galderma, IL-31 receptor alpha, Monoclonal Antibodies, Nemluvio, nemolizumab, nodularis, Prurigo

Nemluvio, nemolizumab, Galderma, European Commission approval, atopic dermatitis, prurigo nodularis, IL-31 receptor alpha, monoclonal antibody

FDA Approves Extended Dosing for Astellas’ Izervay, Intensifying Competition in Geographic Atrophy Treatment

9 months ago talkbio0Tagged Age related macular degeneration, Apellis, Approved, Astellas, dosing, Extension, eye treatment, Geographic Atrophy, IZERVAY, Syfovre, United States Food and Drug Administration

Izervay, Astellas, FDA approval, extended dosing, geographic atrophy, age-related macular degeneration, Syfovre, Apellis, eye treatment

Robert F. Kennedy Jr. Confirmed as HHS Secretary in Close Senate Vote

9 months ago talkbio0Tagged Administration occupational activities, CHARGE Syndrome, Confirmation, Health Policy, Healthy, RFK Jr., Secretary, Senate, Skepticism, Transplant Registry Unified Management Program, Vaccines

RFK Jr., HHS Secretary, Senate confirmation, Trump administration, vaccine skepticism, healthcare policy, Make America Healthy Again

FDA Approves Extended Dosing for Astellas’ Izervay in Geographic Atrophy Treatment

9 months ago talkbio0Tagged Age related macular degeneration, Approved, Astellas, avacincaptad, dosing, Extension, Geographic Atrophy, IZERVAY, pegol, Pharma, United States Food and Drug Administration

Izervay, avacincaptad pegol, geographic atrophy, age-related macular degeneration, FDA approval, extended dosing, Astellas Pharma

FDA Approves Evrysdi Tablets: A Breakthrough in Convenient SMA Treatment

9 months ago talkbio0Tagged Approved, Drug Formulation Process, Evrysdi, genentech, Oral treatment, Risdiplam, Roche (company), Spinal Muscular Atrophy, Tablet Dosage Form, United States Food and Drug Administration

Evrysdi, risdiplam, spinal muscular atrophy (SMA), FDA approval, tablet formulation, oral treatment, Genentech, Roche